Research Topics
| Marek JaremaSummaryAffiliation: Institute of Psychiatry and Neurology Country: Poland Publications
|
Detail Information
Publications
Atypical antipsychotics in the treatment of mood disordersMarek Jarema
III Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
Curr Opin Psychiatry 20:23-9. 2007..Recent literature has been reviewed to show the potential use and usefulness of the atypical medications in patients suffering from depression or mania...
Strategies of long-term treatment of psychotic disordersMarek Jarema
III Department of Psychiatry, Institute of Psychiatry and Neurology, ul Sobieskiego 9, 02 9578 Warszawa, Poland
Neuro Endocrinol Lett 28:13-26. 2007..Such widely accepted standards are valuable tools to help to identify the most appropriate treatment for psychotic conditions, being not necessary adequate to patient's expectations and needs...
[Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial]Marek Jarema
III Kliniki Psychiatrii IPiN w Warszawie
Psychiatr Pol 37:641-55. 2003..The secondary objective was to assess the safety profile and clinical efficacy of the investigated drugs...
Herbal drug treatmentMarek Jarema
3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland
Neuro Endocrinol Lett 29:93-104. 2008..Some herbal formulations, such as St. John's wort, have been analyzed in clinical trials to estimate their real value. The use of other herbal medicines, such as Kava-kava, valerian, and Ginkgo biloba is discussed...
[Acute psychiatric diseases]Joanna Meder
Instytut Psychiatrii i Neurologii, Warszawa
Psychiatr Pol 41:871-938. 2007
Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidoneAdam Wichniak
Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego, Warsaw, Poland
J Psychiatr Res 45:1381-6. 2011..These changes are linked to negative and depressive symptoms...
A few facts from the history of selected biological treatment methods in psychiatryMarek Jarema
3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland
Neuro Endocrinol Lett 29:5-9. 2008..Obviously, at present we are aware that these therapies should be considered far less efficient than modern psychotropic drugs; however, at the time when these methods were used, no other efficient treatment methods were available...
[Subjective and objective evaluation of olanzapine treatment in schizophrenia]Marek Jarema
III Kliniki Psychiatrycznej IPiN w Warszawie
Psychiatr Pol 38:895-909. 2004..The severity of adverse events decreased during the olanzapine treatment. CONCLUSIONS: Olanzapine treatment of patients suffering from schizophrenia proved to be efficacious in both objective and subjective evaluation...
[Current concepts of pharmacological treatment in schizophrenia]Marek Jarema
III Kliniki Psychiatrycznej IPiN w Warszawie
Psychiatr Pol 36:857-68. 2002..It was stated that modern concepts of treatment of schizophrenia do not solely rely on the use of modern drugs, but include the multidirectional therapeutic actions with an active participation of the patient and his/her relatives...
[Pharmacological standards in schizophrenia treatment]Marek Jarema
Psychiatr Pol 40:1171-205. 2006
[Second generation antipsychotics: similarities and differences]Marek Jarema
III Kliniki Psychiatrycznej IPiN w Warszawie
Psychiatr Pol 37:7-28. 2003..At the same time it indicates that obvious differences in action exist inside the group...
[Second generation of neuroleptics--expectations and the reality]Marek Jarema
III Klinika Psychiatryczna Instytutu Psychiatrii i Neurologii w Warszawie
Psychiatr Pol 36:209-16. 2002..The careful selection of the drug and its dosage increases the possibility of good clinical improvement, but more wider use of these drugs is recommended in order to evaluate their practical usefulness...
[The change of quality of life and clinical picture in schizophrenia]Marek Jarema
III Kliniki Psychiatrycznej IPiN w Warszawie
Psychiatr Pol 36:393-402. 2002..After treatment the quality of life was significantly worse in patients who had distinct depression before treatment, than in those without depression or with only slight depression before treatment...
